- Home
- SQNS vs BLUE Comparison
SQNS vs BLUE Comparison
Compare SQNS & BLUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SQNS
- BLUE
- Stock Information
- Founded
- SQNS 2003
- BLUE 1992
- Country
- SQNS France
- BLUE United States
- Employees
- SQNS N/A
- BLUE N/A
- Industry
- SQNS Semiconductors
- BLUE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SQNS Technology
- BLUE Health Care
- Exchange
- SQNS Nasdaq
- BLUE Nasdaq
- Market Cap
- SQNS 85.7M
- BLUE 75.8M
- IPO Year
- SQNS 2011
- BLUE 2013
- Fundamental
- Price
- SQNS $3.14
- BLUE $6.96
- Analyst Decision
- SQNS Strong Buy
- BLUE Hold
- Analyst Count
- SQNS 1
- BLUE 9
- Target Price
- SQNS $7.50
- BLUE $49.14
- AVG Volume (30 Days)
- SQNS 135.2K
- BLUE 199.3K
- Earning Date
- SQNS 02-11-2025
- BLUE 03-25-2025
- Dividend Yield
- SQNS N/A
- BLUE N/A
- EPS Growth
- SQNS N/A
- BLUE N/A
- EPS
- SQNS 1.65
- BLUE N/A
- Revenue
- SQNS $30,555,000.00
- BLUE $53,120,000.00
- Revenue This Year
- SQNS $10.14
- BLUE $145.88
- Revenue Next Year
- SQNS $8.54
- BLUE $239.89
- P/E Ratio
- SQNS $1.83
- BLUE N/A
- Revenue Growth
- SQNS N/A
- BLUE 144.50
- 52 Week Low
- SQNS $0.85
- BLUE $5.80
- 52 Week High
- SQNS $7.43
- BLUE $38.40
- Technical
- Relative Strength Index (RSI)
- SQNS 48.85
- BLUE 39.64
- Support Level
- SQNS $3.00
- BLUE $7.25
- Resistance Level
- SQNS $3.64
- BLUE $8.22
- Average True Range (ATR)
- SQNS 0.21
- BLUE 0.53
- MACD
- SQNS -0.03
- BLUE -0.11
- Stochastic Oscillator
- SQNS 39.76
- BLUE 8.81
About SQNS Sequans Communications S.A.
Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its solutions incorporate baseband processor and radio frequency, transceiver integrated circuits, along with its proprietary signal processing techniques, algorithms, and software stacks. The company's solutions serve as the core wireless broadband communications platform in devices, including smartphones, USB dongles, portable routers, laptops, netbooks, tablets, and other consumer multimedia and industrial devices. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.
About BLUE bluebird bio Inc.
bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.